David Walt, co-founder of Illumina (ILMN), has sold approximately $114 million in ILMN stock over his career. But unlike most insider sellers, Walt has also been buying — making open-market purchases even while maintaining a selling program.
This is one of the rarest and most informative patterns in insider trading data.
Why this pattern is unusual
Most insiders fall into one of two categories:
- Net sellers: They receive stock as compensation and periodically sell for diversification. They never buy on the open market. (90%+ of all insiders)
- Net buyers: Rare — they actively purchase shares with their own money, usually at specific moments of perceived undervaluation.
David Walt is in a third, extremely rare category:
- Seller AND buyer: Maintains a selling program (diversification) while also making occasional open-market purchases (conviction).
This combination is informative because it shows an insider who is actively managing their position — not just passively letting compensation vest and selling on schedule.
How to read the dual pattern
The selling component ($114M career)
- Consistent with long-tenured founder diversification
- Illumina was founded in 1998; Walt has been associated for 27+ years
- Stock has appreciated enormously (from single digits to $100+ at various points)
- $114M in career sales across decades = gradual, planned wealth management
The buying component (the real signal)
When Walt makes open-market purchases (Code P), pay close attention:
- He's spending his own cash at market price — not exercising options
- He's choosing to INCREASE exposure to a stock he already owns heavily
- He has the deepest possible insight into Illumina's technology and competitive position
- The buy breaks his selling pattern — this is a pattern deviation, which is the highest-signal insider event
When founder buying matters most
| Context | Signal strength |
|---|---|
| Buying at all-time highs | Moderate — conviction but not contrarian |
| Buying after a 30%+ decline | Very strong — sees value others don't |
| Buying during sector rotation away from biotech | Strong — thesis conviction despite sector headwinds |
| Buying after a specific negative event (earnings miss, FDA setback) | Extremely strong — disagrees with the market's reaction |
Illumina has faced significant challenges:
- Activist investor pressure from Carl Icahn (2023)
- The failed GRAIL acquisition and subsequent spinoff
- Stock decline from ~$500 peak to ~$100-150 range
- Leadership changes (CEO transitions)
A founder buying during this turbulent period would be an exceptionally strong conviction signal.
The broader lesson: buyer-sellers are the most informative insiders
Insiders who both buy and sell give you the richest data set:
From their selling pattern, you learn:
- Their baseline liquidity needs
- Their normal cadence and size
- What "routine" looks like for this specific person
From their buying pattern, you learn:
- When they see exceptional value
- What price levels trigger their conviction
- Whether they're willing to increase concentration during adversity
From the combination, you learn:
- Their net conviction trajectory
- Whether selling is accelerating or decelerating relative to buying
- The specific price points where they switch from net seller to net buyer
How to use this for ILMN specifically
- Track Walt's recent Form 4 filings: Is he currently in a buying or selling phase?
- Note the price points: At what ILMN price does he buy? At what price does he sell?
- Compare to institutional data: Are 13F filers also accumulating ILMN? If Walt is buying AND hedge funds are entering, the convergence is powerful.
- Monitor for pattern breaks: If Walt stops buying after years of occasional purchases, that absence of buying is itself a signal.
The insider profile as a research tool
David Walt's profile illustrates why looking at a single Form 4 filing in isolation is insufficient. The filing that says "Walt sold $2M" looks bearish. The profile that shows "Walt sold $2M as part of a 20-year pattern, and also bought $500K two months ago" tells a completely different story.
Always check the profile before interpreting any single transaction.
Originally published at 13F Insight
Top comments (0)